NCT05555290View on ClinicalTrials.gov

PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction

PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

November 18, 2024

Study Completion Date

November 18, 2024

Conditions
Asthma
Interventions
COMBINATION_PRODUCT

PT027

When administered PT027, participants will receive 2 actuations of albuterol- budesonide per dose administered as oral inhalations.

COMBINATION_PRODUCT

PT007

When administered PT007, participants will receive 2 actuations of albuterol administered as oral inhalations.

Trial Locations (1)

21046

Research Site, Columbia

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY